DJIA 17,098.45 18.88 0.11%
NASDAQ 4,580.27 22.58 0.50%
S&P 500 2,003.37 6.63 0.33%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

Teva Pharmaceutical's (TEVA) Management Presents at Jefferies Global Healthcare Conference (Transcri

Teva Pharmaceutical's (TEVA) Management Presents at Jefferies Global Healthcare Conference (Transcript)

Teva to Acquire Labrys Biologics, Inc

Actavis Acquires Forest Labs For Brand-Name Drugs

Why Teva Pharmaceuticals (TEVA) Stock Is Up Today

Teva Announces New Organizational Structure and Senior Leadership Changes; Appoints New Global Head

Teva Announces New Organizational Structure and Senior Leadership Changes; Appoints New Global Head of Quality

Teva Pharma: Underpriced And Misunderstood, Identifiable Catalyst

Healthcare Stocks Inching Higher; Mylan Still Looking to Overturn FDA Decision Supporting Teva Exclu

Healthcare Stocks Inching Higher; Mylan Still Looking to Overturn FDA Decision Supporting Teva Exclusivity Period

Sector Update: Healthcare

1 Big Pharma Stock in More Danger than Investors Realize

Is Eli Lilly's lost Alimta patent fight in the UK forshadowing bigger troubles for the big pharma?

Supreme Court + Risky Drug Launch = Billions at Stake

Teva Pharmaceutical Industries Ltd. is trying, not all that successfully, to hold onto its money-making lead MS drug, Copaxone.